Biophytis SA (BPTSY)
8.27
+0.07
(+0.85%)
USD |
OTCM |
May 16, 16:00
Biophytis Cash from Investing (TTM): 0.3879M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3879M |
| June 30, 2023 | -1.205M |
| December 31, 2022 | -0.0032M |
| June 30, 2022 | -0.0044M |
| December 31, 2021 | 14.67M |
| June 30, 2021 | -0.1243M |
| December 31, 2020 | -15.16M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0612M |
| December 31, 2017 | -0.1383M |
| June 30, 2017 | -0.1536M |
| December 31, 2016 | -0.1421M |
| June 30, 2016 | -0.0721M |
| December 31, 2015 | -0.0066M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-15.16M
Minimum
Dec 2020
14.67M
Maximum
Dec 2021
-0.1867M
Average
-0.0328M
Median
Cash from Investing (TTM) Benchmarks
| Edap TMS SA | -4.703M |
| DBV Technologies SA | -2.982M |
| Cellectis SA | -15.51M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | 176.54M |